ABT
NYSEAbbott Laboratories COM
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices.
Contexte du mouvement
Secteur- Le secteur (Healthcare, XLV) a bougé de 1.59% : mouvement largement sectoriel.
Drivers prévisibles à venir
- Détachement du dividende · 15/10/2026 (J+5)
- Échéances d'options · 16/10/2026 (J+6)
- Rebalancement d'indices · 18/12/2026 (J+69)
Contexte quantitatif — information à titre indicatif, pas un conseil en investissement.
Dividendes & société
ABT · USD
Sources : yahoo. Informations à titre indicatif, pas un conseil.
Consensus analystes
Sources : yahoo. Consensus d'analystes sell-side — information à titre indicatif, pas un conseil en investissement.
Contenu réservé aux membres
Créez un compte gratuit pour accéder à l'intelligence de marché de ABT : corrélations, insights IA et actualités.
Accès libre sur les actions et ETF les plus suivis
Actualités liées
Budget de l'Union européenne : l'Irlande propose une réduction des dépenses de 8 % - Les Echos
Budget de l'Union européenne : l'Irlande propose une réduction des dépenses de 8 % Les Echos
Abbott (ABT) Stock Could Be 24% Overvalued After Heart Failure News
Abbott Laboratories has had a rough year in the market, and the recent product news now puts a sharper spotlight on whether the current share price is properly grounded in the cash the business can generate. With a Discounted Cash Flow (DCF) view available, the question is how the recent market drop lines up with the long term cash flow profile investors are effectively paying for today. Over the past year, Abbott Laboratories shares have fallen 23.1%, which puts recent sentiment and the...
Actualités du 09 octobre 2026
Actualités du 09 octobre 2026 Boursorama
Patriot Mobile, opérateur de téléphonie mobile chrétien-conservateur, dépose une demande d'introduction en bou
Patriot Mobile, opérateur de téléphonie mobile chrétien-conservateur, dépose une demande d'introduction en bou Boursorama
Base Electron dépose en toute confidentialité une demande d'introduction en Bourse aux États-Unis
Base Electron dépose en toute confidentialité une demande d'introduction en Bourse aux États-Unis Boursorama
BOURSE DU CANADA-Le TSX enregistre sa plus forte hausse en cinq semaines alors que les anticipations de hausse
BOURSE DU CANADA-Le TSX enregistre sa plus forte hausse en cinq semaines alors que les anticipations de hausse Boursorama
Wall Street termine la semaine en hausse - Investir Les Echos
Wall Street termine la semaine en hausse Investir Les Echos
vVardis prépare son entrée à Wall Street après avoir triplé ses revenus
vVardis prépare son entrée à Wall Street après avoir triplé ses revenus Boursorama
Is It Worth Investing in Abbott (ABT) Based on Wall Street's Bullish Views?
The average brokerage recommendation (ABR) for Abbott (ABT) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?
Abbott Laboratories (ABT) is Attracting Investor Attention: Here is What You Should Know
Recently, Zacks.com users have been paying close attention to Abbott (ABT). This makes it worthwhile to examine what the stock has in store.
Abbott Laboratories (ABT) Ties Glucose Tracking To Live Nutrition Coaching In Exclusive Deal
Abbott Laboratories (NYSE:ABT) and Berry Street announced an exclusive US partnership to link glucose tracking with live nutrition coaching. The program pairs Abbott's over the counter Lingo glucose biowearable with Berry Street dietitians who deliver insurance supported coaching sessions. The collaboration targets metabolic health support for millions of Americans by combining real time glucose data with personalized lifestyle guidance. This new Abbott and Berry Street glucose coaching...
Is Abbott Laboratories (ABT) a Dividend Bargain After Its 2026 Selloff?
Abbott Laboratories (NYSE:ABT) is a business that is not showcasing any rapid growth trends. However, what makes it an attractive investment prospect is the company’s consistent track record of incremental dividends, with 411 consecutive quarterly payouts since 1924. Along with the company’s underlying business mix, it makes Abbott a suitable investment for dividend hunters. The […]
How FDA-Approved CardioMEMS App Integration At Abbott Laboratories (ABT) Has Changed Its Investment Story
In early October 2026, Abbott Laboratories received FDA approval for updates to its CardioMEMS HF System, allowing U.S. heart failure patients to see pulmonary artery pressure readings and receive clinician-guided medication adjustments via the new CardioGuide HF App and Dynamic Treatment Plan on their smartphones. This move deepens Abbott’s push into connected cardiac care by pairing an established implantable sensor with patient-facing digital tools that can support earlier intervention...
Here Are Wednesday’s Top Wall Street Analyst Research Calls: Abbott Laboratories, AppFolio, Delek US Holdings, Flutter Entertainment, Honeywell Aerospace, Intuitive Surgical, Marvell, NetApp, and More
Stocks shattered records again Tuesday while oil surged, gold hit new highs, and crypto swung wildly, setting the stage for a fresh wave of analyst moves on names like Marvell, Intuitive Surgical, and NetApp that could reshape portfolios heading into the rest of the week.
Abbott (ABT) Stock Drops Despite Market Gains: Important Facts to Note
Abbott (ABT) closed the most recent trading day at $98.16, moving 1.94% from the previous trading session.
Les données sont fournies à titre informatif. PunkMarket n'est pas un conseiller financier.